跳至主要内容
临床试验/NCT00988026
NCT00988026Unknown4 期

Safety and Efficacy Comparison of Minocycline Microgranules vs Lymecycline in the Treatment of Mild to Moderate Acne. Randomized, Double Blind, Parallel and Prospective Clinical Trial for 8 Weeks

Darier1 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
Darier
入组人数
168
试验地点
1
主要终点
Number of inflammatory and non-inflammatory acne lesions

研究概览

简要总结

This is a clinical trial to compare the benefits and possible adverse events of two antibiotic treatments for mild to moderate acne. It is expected that minocycline microgranules will be more effective than lymecycline with a better adverse events profile.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
14 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Both gender
  • 14 to 30 years old
  • Mild to moderate acne
  • Face localization
  • At least 20 non-inflammatory lesions OR
  • At least 15 inflammatory lesions OR
  • At least 30 total lesions AND
  • Less than 5 nodular lesions

排除标准

  • Patients younger than 14 or older than 30 years old
  • Less than 20 non-inflammatory lesions OR
  • Less than 15 inflammatory lesions OR
  • Less than 30 total lesions
  • Patients with severe acne
  • More than 5 nodular lesions OR
  • More than 50 inflammatory lesions OR
  • More than 125 total lesions
  • Pregnant women
  • Lactating women

研究组 & 干预措施

Minocycline 100 mg

Experimental

Minocycline

干预措施: Minocycline vs Lymecycline (Drug)

Lymecycline 300 mg

Active Comparator

Group B: Lymecycline

干预措施: Minocycline vs Lymecycline (Drug)

结局指标

主要结局

Number of inflammatory and non-inflammatory acne lesions

时间窗: 8 weeks

次要结局

  • Incidence of local and systemic adverse events(8 weeks)

研究者

发起方
Darier
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验